InvestorsHub Logo

ziploc_1

07/01/19 8:19 AM

#199257 RE: flubber #199256

flubber:......It is striking that Array management had the balls to reject a 62% premium offer at a time when there was no other offer on the table...we Amarin investors are just amateurs when it comes to risk taking.

KCSVEN

07/01/19 8:29 AM

#199260 RE: flubber #199256

That article lacks many details but makes Pfizer look like poor negotiators. They even throw in this unnecessary comment
"Pfizer CEO Albert Bourla, new to the job of buying companies" as if even the writer can't believe how poorly Pfizer negotiated.

Good job by Array management and board, played that really well, hopefully if Amarin goes down that route they act similarly.

sts66

07/01/19 4:15 PM

#199329 RE: flubber #199256

So much for the "companies are bought, not sold" theory.....from the looks of it ARRY execs were out to enrich themselves more than anything else. Hard to believe nothing leaked for two years too - almost impossible to believe, actually, especially with so many players involved.

Also, didn't some new regulations put the kibosh on golden parachutes, limiting them to a low multiple of prior annual earnings? I recall a discussion about that here a while back about some kind of limit on what JT could get if let go after a BO, don't remember the exact details, but 3x stands out for some reason.